Advanced Filters
noise

Delft, Netherlands Clinical Trials

A listing of Delft, Netherlands clinical trials actively recruiting patients volunteers.

Found 291 clinical trials
S Stijn Koolen, PhD

Data Collection in Lutetium Treated Prostate Cancer: Recording of Progression and Tumor Characteristics

This prospective study aims to collect data and blood biomarkers from patients undergoing Lu-PSMA therapy at the Erasmus MC. In doing so, it will provide real-world efficacy and safety data on the drug, gather dosimetry data and explore putative biomarkers to identify patients who most benefit from Lu-PSMA treatment.

18 years of age Male Phase N/A
I Ista

Effects of a Digital Diary on the Psychological Well-being of Former ICU Patients.

Previous research on the impact of a diary on mental symptoms of PICS, PICS-F, and quality of life in former ICU patients and their relatives has focused specifically on a paper diary. While there has been research on the experiences of former ICU patients, relatives, and ICU nurses regarding the …

18 years of age All Phase N/A
L Lukas K van Vugt, Drs.

Reduced-dose Alemtuzumab for Kidney Transplant Rejection

Prospective, follow-up study of kidney transplant recipients treated with alemtuzumab anti-rejection therapy for severe or glucocorticoid-resistant kidney transplant rejection.

18 years of age All Phase N/A
M Marieke Wouters, PhD

Implementation of Bright Light Therapy ID

Many adults with intellectual disabilities (ID) have depressive symptoms, which negatively impact their quality of life. A lot of of the non-medicinal forms of treatment are not or hardly suitable for people with ID. Bright light therapy (BLT) seems to be a good option. Earlier research has shown that BLT …

18 years of age All Phase N/A
J Jason den Duijn

Pro-active Monitoring of Vital Signs in Oncology Patients Using a Smartwatch

The goal of this single center prospective observational study is to determine the effect of chemotherapy on (the change in) vital parameters. The main question it aims to answer are: Can changes in vital parameters be measured by using a Fitbit in patients with cancer while undergoing chemotherapy. Participants will …

18 years of age All Phase N/A

Surveillance of Respiratory Viruses in Healthcare and Animal Workers

Outbreaks with viruses occur continuously, and novel viruses or new variants of existing viruses can surface after a zoonotic event or human-to-human transmission. This project proposal is designed to detect early circulation of (novel) respiratory viruses in both symptomatic and asymptomatic participants, either by direct detection of the virus or …

18 years of age All Phase N/A

Preterm Immune System Development and Response to Immunization

In this study the response to vaccination and development of the immune system in very preterm infants upon the current vaccination schedule will be compared to healthy term infants.

1 - 2 years of age All Phase N/A
J Jozephien Robbemont

Preconception Carrier Screening at the Erasmus MC

Rationale A recent advisory report by the 'Health Council' has recommended that all prospective parents should have the opportunity to undergo preconception carrier screening. Consequently,there will no longer be any prerequisites for referring a couple. It is expected that there will be an increase in the number of prospective parents …

18 years of age All Phase N/A
Y Yasemin Türk, MD, PhD

Inhaler Adherence and Inhalation Technique Assessed by a Smart Spacer in Patients with Severe Asthma on Biologics

Severe refractory asthma affects about 3.5% of asthma patients, often necessitating biologic therapy in addition to standard treatment. However, little is understood about maintenance and reliever inhalation medication adherence in these cases which might impact overall biologic response. Objectively monitoring inhalation medication adherence remains a significant challenge. The Smart AeroChamber® …

18 years of age All Phase N/A

Short Term Outcomes After PRoton and PhotoN RadiOtherapy for IDH Mutated Grade 2 and 3 Gliomas

Rationale Proton beam therapy has recently become available for the treatment of patients with WHO grade 2 and 3 IDH mutated (IDHmt) glioma in the Netherlands. The dose distributions associated with proton therapy have substantially reduced the volume of the normal brain irradiated with low and intermediate radiotherapy doses. Whether …

18 years of age All Phase N/A

Simplify language using AI